“I now realize that love can bloom and it can heal, in the most unexpected places, under the harshest of circumstances,” Contemprato remarked.
Tala Hospital: Then and now
Contemprato is just one of the many patients that Tala Hospital helped heal in the entire Luzon region.
Established in 1940, the medical facility opened its doors during a time when leprosy cast a shadow of fear and ostracization. As a designated leprosarium, it provided a compassionate sanctuary for countless individuals battling the disease.
Witnessing the dedication of medical personnel and the power of early research, the hospital saw a significant drop in leprosy cases by 1970. This success story was not just a medical breakthrough–it turned into an opportunity.
In a remarkable step, the hospital expanded its mandate to serve the broader community. It opened its doors to non-leprosy patients, transforming from a specialized center to a comprehensive healthcare provider.
Today, DJNRMHS stands as a Level 3 licensed hospital, a designation signifying its excellence in patient care and commitment to advanced medical practices. It continues to serve as the premier training and research center for leprosy management in the Philippines, ensuring its expertise extends beyond its own walls.
Simultaneously, it caters to the diverse healthcare needs of communities in North Caloocan, Bulacan and neighboring areas, offering a variety of medical services from general consultations to specialty care.
Ongoing threat
Hansen’s disease is a chronic infectious disease caused by the bacterium Mycobacterium leprae. It primarily affects the skin, nerves, and mucous membranes. Leprosy is not highly contagious and is usually transmitted through prolonged close contact with an infected person.
According to the World Health Organization (WHO), leprosy, a neglected tropical disease (NTD), continues to affect people in over 120 countries. While significant progress has been made, new cases still emerge – around 200,000 each year.
The good news? Leprosy was eliminated as a public health problem globally in 2000 and most countries followed suit by 2010. This means that less than 1 person per 10,000 has the disease. The number of new cases has been steadily declining worldwide, including in all WHO regions.
In Tala Hospital, particularly, the number of leprosy cases per year significantly declined from 101 in 2012 to 26 in 2021.
However, some areas still face significant challenges. As of 2019, three countries – Brazil, India, and Indonesia–reported over 10,000 new cases each. Thirteen others, including Bangladesh, Ethiopia, Myanmar, and the Philippines, saw between 1,000 and 10,000 new cases.
While strides have been made, eradicating leprosy requires continued vigilance and focused efforts in areas with high disease burden. Increasing access to early diagnosis and treatment, tackling stigma, and strengthening healthcare systems are crucial steps towards a completely leprosy-free future.
Early detection and treatment of leprosy are crucial to prevent severe complications and disabilities. Treatment typically involves a combination of antibiotics and other medications. With proper treatment, most people with leprosy can be cured and live a normal life. By working together, we can help eliminate leprosy and its associated stigma.
Leprosy Control Week
In the Philippines, Leprosy Control Week is an annual observance that aims to raise awareness about leprosy and promote its prevention and control. It is held every last week of February in accordance with Proclamation No. 467, which was signed by then President Diosdado Macapagal in 1965.
During Leprosy Control Week, various activities are conducted to educate the public about the disease, including its causes, symptoms, and treatment. These activities may include seminars, workshops, lectures, and media campaigns. The week also serves as an opportunity to provide free or subsidized leprosy screening and treatment services to those in need.
This year, the Dermatology Department and Leprosy Care Service of the Tala Hospital partnered with the Philippine Dermatological Society to conduct an AFS (Acid Fast Staining) Demo and Training among dermatology residents. AFS is a test that can be used to diagnose leprosy.